Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: A case report and further case studies

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Yu, Jing ^a   Bhargava, Rohit ^a   Dabbs, David J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CATENIN; CDH1 PROTEIN, HUMAN; DELTA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN; MUC1 PROTEIN, HUMAN; MUCIN 1; TUMOR MARKER;

AGED; ARTICLE; BIOPSY; BREAST TUMOR; CANCER INVASION; CASE REPORT; CHEMISTRY; COLLOID CARCINOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; PATHOLOGY; SEGMENTAL MASTECTOMY; TISSUE MICROARRAY; UPREGULATION;

ADENOCARCINOMA, MUCINOUS; AGED; BIOPSY; BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; CATENINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MASTECTOMY, SEGMENTAL; MUCIN-1; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77953474864     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-36     Document Type: Article

References (34)

1. Gad A, Azzopardi JG. Lobular carcinoma of the breast: a special variant of mucin-secreting carcinoma. J Clin Pathol 1975, 28:711-716. 10.1136/jcp.28.9.711, 475812, 170320.
2. Harris M, Vasudev KS, Anfield C, Wells S. Mucin-producing carcinomas of the breast: ultrastructural observations. Histopathology 1978, 2:177-188. 10.1111/j.1365-2559.1978.tb01708.x, 208954.
3. Rosen PP. Invasive Lobular Carcinoma. Rosen's Breast Pathology 2009, 690-720. Philadelphia, PA, USA: Lippincott Williams & Wilkins, Rosen PP, 3.
4. Tan PH, Tse GM, Bay BH. Mucinous breast lesions: diagnostic challenges. J Clin Pathol 2008, 61:11-19. 10.1136/jcp.2006.046227, 17873114.
5. Bertucci F, Orsetti B, Negre V, Finetti P, Rouge C, Ahomadegbe JC, Bibeau F, Mathieu MC, Treilleux I, Jacquemier J, Ursule L, Martinec A, Wang Q, Benard J, Puisieux A, Birnbaum D, Theillet C. Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene 2008, 27:5359-5372. 10.1038/onc.2008.158, 2902854, 18490921.
6. Bhargava R, Striebel J, Beriwal S, Flickinger JC, Onisko A, Ahrendt G, Dabbs DJ. Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers. Int J Clin Exp Pathol 2009, 2:444-455. 2655155, 19294003.
7. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752. 10.1038/35021093, 10963602.
8. Sorlie T. Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods Mol Biol 2007, 360:91-114.
9. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
10. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003, 100:8418-8423. 10.1073/pnas.0932692100, 166244, 12829800.
11. Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K, Kreike B, Reis-Filho JS. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol 2010, 220:45-57. 10.1002/path.2629, 19877120.
12. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Karesen R, Botstein D, Borresen-Dale AL, Jeffrey SS. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004, 15:2523-2536. 10.1091/mbc.E03-11-0786, 420079, 15034139.
13. Dabbs DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 2007, 31:427-437. 10.1097/01.pas.0000213386.63160.3f, 17325485.
14. Foote FW, Stewart FW. Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol 1941, 17:491-496. 493, 1965212, 19970575.
15. Cserni G. Reproducibility of a diagnosis of invasive lobular carcinoma. J Surg Oncol 1999, 70:217-221. 10.1002/(SICI)1096-9098(199904)70:4<217::AID-JSO3>3.0.CO;2-8, 10219016.
16. Kiaer H, Andersen JA, Rank F, Pedersen BV. Quality control of patho-anatomical diagnosis of carcinoma of the breast. Acta Oncol 1988, 27:745-747. 10.3109/02841868809091779, 2851305.
17. Van Bogaert LJ, Maldague P. Infiltrating lobular carcinoma of the female breast. Deviations from the usual histopathologic appearance. Cancer 1980, 45:979-984. 10.1002/1097-0142(19800301)45:5<979::AID-CNCR2820450524>3.0.CO;2-Y, 7260850.
18. Rosa M, Mohammadi A, Masood S. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?. Pathol Int 2009, 59:405-409. 10.1111/j.1440-1827.2009.02385.x, 19490472.
19. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993, 143:1731-1742. 1887260, 8256859.
20. Dabbs DJ, Kaplai M, Chivukula M, Kanbour A, Kanbour-Shakir A, Carter GJ. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol 2007, 15:260-266. 10.1097/01.pai.0000213128.78665.3c, 17721269.
21. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001, 115:85-98. 10.1309/FDHX-L92R-BATQ-2GE0, 11190811.
22. Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 2001, 115:534-542. 10.1309/B0DD-4M7H-GJG1-7KCW, 11293901.
23. Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends Cell Biol 2006, 16:467-476. 10.1016/j.tcb.2006.07.006, 16904320.
24. Chu JS, Chang KJ. Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast. Cancer Lett 1999, 142:121-127. 10.1016/S0304-3835(99)00161-5, 10424790.
25. Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 2005, 18:1295-1304. 10.1038/modpathol.3800445, 15976813.
26. Rahn JJ, Dabbagh L, Pasdar M, Hugh JC. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer 2001, 91:1973-1982. 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A, 11391575.
27. Kondo K, Kohno N, Yokoyama A, Hiwada K. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res 1998, 58:2014-2019.
28. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996, 7:565-577. 275910, 8730100.
29. Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J Biol Chem 1997, 272:12492-12494. 10.1074/jbc.272.19.12492, 9139698.
30. Yang SZ, Kohno N, Yokoyama A, Kondo K, Hamada H, Hiwada K. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. Int J Oncol 2001, 18:541-548.
31. Gunther K, Merkelbach-Bruse S, Amo-Takyi BK, Handt S, Schroder W, Tietze L. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization. J Pathol 2001, 193:40-47. 10.1002/1096-9896(2000)9999:9999<::AID-PATH745>3.0.CO;2-N, 11169514.
32. Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, Monson JR, Kerin MJ. Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 2000, 86:494-500. 10.1002/(SICI)1097-0215(20000515)86:4<494::AID-IJC8>3.0.CO;2-O, 10797261.
33. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997, 74:513-517. 10.1002/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.0.CO;2-6, 9355973.
34. Richard F, Pacyna-Gengelbach M, Schluns K, Fleige B, Winzer KJ, Szymas J, Dietel M, Petersen I, Schwendel A. Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer 2000, 89:305-310. 10.1002/1097-0215(20000520)89:3<305::AID-IJC15>3.0.CO;2-8, 10861509.